Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This is a study with two treatment sequences and two treatment periods that will assess the
safety and efficacy of exenatide treatment in patients with type 2 diabetes who have
inadequate glycemic control using metformin or sulfonylurea and for whom insulin is the next
appropriate step in diabetes treatment.